Processing your request


please wait...

 | Case Page

 | Case Page |

Case Page

 

Tesaro Inc.

Case Summary

Tesaro Inc. Securities Litigation

Case Summary

Case Status:    ONGOING    
On or around 05/16/2019 (Ongoing date of last review)

Filing Date: January 17, 2018

According to the Complaint, Tesaro is an oncology-focused biopharmaceutical company that identifies, acquires, develops, and commercializes cancer therapeutics and oncology supportive care products in the United States.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. The Complaint alleges that specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) substantial undisclosed health risks, including anaphylaxis and anaphylactic shock, were associated with Tesaro’s intravenous formulation of Varubi; and (ii) as a result of the foregoing, Tesaro’s shares traded at artificially inflated prices during the Class Period, and class members suffered significant losses and damages.

On May 4, 2018, the Court issued an Order appointing Lead Plaintiff and Counsel. This case was voluntarily dismissed by the Lead Plaintiff on October 12. A related case continues under Docket 18-CV-12352.

On January 29, 2019, the Court issued an Order appointing Lead Plaintiff and Counsel. Lead Plaintiff filed an amended Complaint on April 1.

Company & Securities Information

Defendant: Tesaro Inc.

COMPANY INFORMATION:

Sector: Healthcare
Industry: Biotechnology & Drugs
Headquarters: United States

SECURITIES INFORMATION:

Ticker Symbol: TSRO
Company Market: NASDAQ
Market Status: Public (Listed)

About the Company & Securities Data


"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.

In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.

First Identified Complaint

Roger Bowers, et al. v. Tesaro Inc., et al.

COURT: D. Massachusetts
DOCKET #: 18-CV-10086
JUDGE: Hon. Allison D. Burroughs
DATE FILED: 01/17/2018
CLASS PERIOD START: 03/14/2016
CLASS PERIOD END: 01/12/2018
PLAINTIFF FIRMS NAMED IN COMPLAINT:
  1. Andrews DeValerio LLP
  2. Bronstein, Gewirtz & Grossman, LLC (New York)
  3. Pomerantz LLP (New York)
First Identified Complaint (FIC) Filings:
No Document Title Filing Date
1 Class Action Complaint 01/17/2018
2 U.S. District Court Civil Docket 05/04/2018
3 Order Granting Zev Crawley's Motion for Appointment as Lead Plaintiff and Approval of Selection of Counsel 05/04/2018

Reference Complaint

LSI Design and Integration Corp., et al. v. Tesaro Inc., et al.

COURT: D. Massachusetts
DOCKET #: 18-CV-12352
JUDGE: Hon. Allison D. Burroughs
DATE FILED: 04/01/2019
CLASS PERIOD START: 11/04/2016
CLASS PERIOD END: 11/14/2016
PLAINTIFF FIRMS NAMED IN COMPLAINT:
  1. Andrews DeValerio LLP
    265 Franklin Street, Suite 1702, Andrews DeValerio LLP, MA 02110
    617.936.2796 ·
  2. Pomerantz LLP (New York)
    600 Third Avenue, 20th Floor, Pomerantz LLP (New York), NY 10016
    212.661.1100 212.661.8665 · info@pomerantzlaw.com/
Reference Complaint (REF) Filings:
No Document Title Filing Date
1 Class Action Complaint 11/09/2018
2 U.S. District Court Civil Docket 04/01/2019
3 Class Action Complaint 04/01/2019

Related District Court Filings

—Related District Court Filings Data is not available
 
 

Cases